Cytokinetics, Incorporated · NASDAQ:CYTK

Harrington Robert Arthur received 195 Cytokinetics, Incorporated shares as an award (Form 4)

Traded Oct 16, 2026 · Filed Oct 20, 2026

On Oct 16, 2026, Harrington Robert Arthur (Director) received 195 Cytokinetics, Incorporated shares as an award at US$63.92 for US$12,464, leaving 22,127 shares. Filed Oct 20, 2026 (Form 4).

Awarded
195 shares
Price
US$63.92
Value
US$12,464
Holding after
22,127 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 16, 2026Common StockAward195US$63.9222,127Direct

Source

Download original · View original at SEC

Related